The global Cell Lysis & Disruption Market size is expected to reach USD 5.65 billion by 2025 registering a CAGR of 8.31%, according to a new report by Grand View Research, Inc. Demand for cell lysis & disruption is driven by the immense growth of the biotechnology sector globally. This is majorly due to the high adoption of biotech processes in the pharmaceutical, agricultural, and bio-services industries.
Technological developments in procedures involved to release cellular organelles have paved the way for higher adoption of cell disruption methods. As retrieval and purification of biopharmaceuticals involve cell disruption, a rise in demand for biopharma would lead to the subsequent growth of the market. In addition, advancements in the field of proteomics, metabolomics, and personalized medicine are expected to fuel progressive changes in this sector. However, the high cost of equipment coupled with the dearth of skilled professionals is expected to restrain revenue generation to a certain extent.
The restraint can be addressed as the government organizations are releasing substantial funds to fuel development in the biotechnology sector. Merck KGaA; Thermo Fisher Scientific, Inc.; Qiagen NV; F. Hoffmann-La Roche Ltd; Becton Dickinson & Company (BD); Bio-Rad Laboratories, Inc.; Danaher Corporation; Claremont BioSolutions, LLC; and Miltenyi Biotec GmbH are the prominent companies in this market. These companies have undertaken strategies, such as new product development and strategic alliances, to maintain their market share.
Request a Sample Copy of the Global Cell Lysis & Disruption Market Research Report @ https://www.grandviewresearch.com/industry-analysis/cell-lysis-dissociation-market/request/rs1
Further key findings from the study suggest:
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/5382/ibb
Grand View Research has segmented the global cell lysis & disruption market on the basis of technique, product, cell type, application, end use, and region:
Cell Lysis & Disruption Technique Outlook (Revenue, USD Million, 2014 – 2025)
Cell Lysis & Disruption Product Outlook (Revenue, USD Million, 2014 – 2025)
Cell Lysis & Disruption Cell Type Outlook (Revenue, USD Million, 2014 – 2025)
Cell Lysis & Disruption Application Outlook (Revenue, USD Million, 2014 – 2025)
Cell Lysis & Disruption End Use Outlook (Revenue, USD Million, 2014 – 2025)
Cell Lysis & Disruption Regional Outlook (Revenue, USD Million, 2014 – 2025)
Browse Related Category @
Neuroscience Market:The global neuroscience market size was valued at USD 28.42 billion in 2016 and is expected to grow at a CAGR of 3.1% over the forecast period.
Orthobiologics Market: The industry is primarily driven by the increasing number of orthopedic procedures globally as a consequence of an upsurge in accidents and obesity.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/cell-lysis-dissociation-market